News
Intravenous belimumab plus SOC vs placebo plus SOC was not linked to an increased risk for infection among patients with SLE.
Patients with systemic lupus erythematosus with a history of cutaneous lupus erythematosus are more likely to have high ...
Lolo Lekgoane’s life changed when she was diagnosed with systemic lupus erythematosus. The Mahikeng resident faced immense challenges, including giving up her job, losing mobility and enduring ...
Viewing lupus decision aids without interruption leads to better patient-reported outcomes, regardless of whether they are ...
Incorporating systemic lupus erythematosus disease activity score (SLEDAS) criteria may enhance treat-to-target strategies ...
Jaguar Jonze will be part of the national team representing Australia at the Freediving World Championship in Cyprus this ...
Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced the promotion of Sanam Pangali to ...
A 43-year-old man presents requesting screening for sexually transmitted infections (STIs). His medical history is remarkable for systemic lupus erythematosus (SLE), and he is currently receiving no ...
Cullinan's innovative approach and Zipalertinib's potential approval in 2026 position it as a promising biotech investment.
You might associate autoimmune conditions with symptoms like skin disease, chronic pain, and fatigue. A less-discussed ...
The FDA has approved Benlysta for SC administration using an autoinjector in patients 5 years of age and older with active LN.
Meanwhile, RemeGen can acquire around 23% of Vor Bio's enlarged issued share capital through the $80 million in warrants, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results